POST-HEPATIC JAUNDICE
Clinical trials for POST-HEPATIC JAUNDICE explained in plain language.
Never miss a new study
Get alerted when new POST-HEPATIC JAUNDICE trials appear
Sign up with your email to follow new studies for POST-HEPATIC JAUNDICE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Old drug, new hope? pentoxifylline trial targets jaundice
Disease control CompletedThis completed Phase 2 trial tested whether the drug pentoxifylline can help people with jaundice caused by liver or bile duct problems. 45 adults took 400 mg of pentoxifylline twice daily for 3 months, alongside standard care. Researchers measured changes in antioxidant levels, …
Matched conditions: POST-HEPATIC JAUNDICE
Phase: PHASE2 • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a common supplement ease jaundice? new trial investigates
Disease control CompletedThis completed Phase 2 trial tested whether N-acetylcysteine (NAC), a common antioxidant supplement, can help people with jaundice caused by liver or bile duct issues. 44 adults took NAC twice daily for 3 months alongside standard care. Researchers measured changes in antioxidant…
Matched conditions: POST-HEPATIC JAUNDICE
Phase: PHASE2 • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC